Liberia's Ministry for Health and Social Welfare via the United States Agency for International Development. The Liberian armed forces and security sector stepped back their response after the West Point shooting of a civilian. 8 The British military worked-in principle-under the direction of a civilian led by the UK's Department for International Development, but integrated some personnel within the Sierra Leone armed forces. Although some militaries provided clinical care, others refused even to transport biological samples and patients. 6 Some governments now indicate that they are prepared to revise their military doctrine, incorporating civil-military cooperation in health as a regular activity. 9, 10 However, the involvement of military personnel in such pursuits remains controversial and raises questions about their eff ects on humanitarian principles, personnel, and practices. 11, 12 Civil-military cooperation during the 2014 Ebola outbreak proved necessary and helped the aff ected countries to contain the virus sooner, ultimately saving lives. But more evidence, analysis, and guidelines are needed about the types of health activities that military personnel can undertake in humanitarian crises before we witness, and need to respond to, another major disease outbreak. 2 The study's design would have been strengthened, however, had it been guided more completely by fi ndings from previous trials. [3] [4] [5] Moreover, its results need to be understood in the context of usual care after FNP was added to local services. I raise these issues to encourage a deeper conversation within scientifi c and policy communities about how best to use scarce research resources aimed at improving the early health and development of vulnerable populations.
*
As Robling and colleagues note, US trials identifi ed that programme benefi ts, such as mothers' use of cashassistance welfare, timing of subsequent pregnancies, verifi ed reports of child maltreatment, injuries and ingestions, and language and cognitive development, were most pronounced in families living in concentrated disadvantage and, for children, those born to mothers who had few psychological resources to cope with adversity. [3] [4] [5] The UK FNP has focused on young mothers (<20 years of age) because their children are at risk of compromised development, 6 and maternal age makes it easy to identify who qualifi es. 7 However, young mothers vary substantially in the extent to which they have overlapping challenges, such as fi nancial diffi culties, depression, and substance misuse. 6 Positive FNP eff ects identifi ed in a Dutch trial 8, 9 of 460 disadvantaged women on outcomes such as child maltreatment, children's internalising behavioural problems, and intimate partner violence might be attributed, at least partly, to its serving highly vulnerable mothers, irrespective of their age. Robling and colleagues' trial examined a set of possible moderators of FNP eff ects, but it was not designed to estimate eff ects with those most vulnerable.
Moreover, we need to consider what usual care was in Robling and colleagues' study. 2 How did eff orts of teenage pregnancy midwives and health visitors aff ect estimates of FNP's added value? The usual-care group, for instance, received a mean of 16·25 (SD 12·15) visits by health visitors-a number probably even higher in those at risk. In view of the fact that health visitors in this trial were informed of mothers' service assignments and directed not to visit families in FNP, the 8·6 (SD 13·74) mean number of health-visitor encounters reported by mothers in FNP must be interpreted with caution. FNP records show a mean of 39·28 (SD 15·19) FNP visits completed during pregnancy through to the age of 2 years; this represents excellent maternal engagement and is probably more than enough to help low-risk mothers. 10 Additionally, FNP and usual-care eff ects on prenatal smoking should be placed in the context of other smoking interventions. As noted in the supplementary materials, 2 women in FNP identifi ed as smokers at registration quit at a rate of 17% (49 of 293) compared with 17% (49 of 297) of those in usual care. Although smoking cessation as an outcome overlooks women identifi ed as smokers at the end of pregnancy who were not classifi ed as smokers at registration, it allows us to put the prenatal smoking eff ects in the trial into context. 11 These cessation rates are much larger than those identifi ed for most prenatal counselling and education interventions for women who smoked at baseline, and in which cessation is biochemically validated (ie, 9-11%, calculated from studies reported in a review of the scientifi c literature). 11 Thus, both usual care and FNP were comparatively successful, notwithstanding how much more needs to be done to reduce prenatal cigarette smoking. By contrast, neither FNP nor usual care prevented subsequent pregnancy within 24 months after delivery of the fi rst child (66% in both groups). These high rates make me wonder whether this outcome has the same functional meaning in this sample as it does elsewhere. 12 The two primary child outcomes selected for Robling and colleagues' trial 2 are not outcomes that FNP claims to aff ect. There were no previous replicated eff ects on birthweight or children's accident and emergency department encounters as operationalised in this trial. It is noteworthy that this accident and emergency outcome combines all emergency encounters and hospital admissions into a single yes or no variable. This categorisation does not distinguish, for example, between a concerned parent taking a child with a possible ear infection to accident and emergency when GP care is unavailable, and a comatose child admitted for
The Washington Post/Contributor abusive head trauma. The higher rate of an accident and emergency outcome encounter in the FNP group (81% vs 77%) might represent heightened parental concern and raises questions about this variable's meaning.
Two child outcomes of clear public health importance aff ected in previous trials were not selected as primary outcomes. The fi rst is language or cognitive development, which was measured objectively in earlier trials.
3-5 Robling and colleagues' study 2 would have been strengthened had its designers identifi ed language as a primary outcome and measured it directly. In view of previous replicated eff ects, the signifi cant intervention-control diff erences in maternally reported language development (and language and cognitive development concerns) in this trial are promising: at the age of 24 months, children in the FNP group had mean Early Language Milestone percentile values of 60·8 (SD 31·4) versus 55·7 (SD 31·4) for children in the usual-care group; at age 18 months, language development concerns (children not meeting milestones) were present for 84 (17%) of 490 in the FNP group versus 110 (24%) of 455 for those in usual care; and at 24 months, cognitive development concerns were present for 46 (8%) of 569 children in the FNP group versus 66 (13%) of 522 for those in usual care. Both children in FNP and usual care exceeded the median normative values for age-matched children assessed with the Early Language Milestone; both groups were faring better than most children of their age.
The second outcome of importance is serious injury, often an indication of maltreatment in young children. Although more safeguarding was reported in FNP than in usual-care families, this is consistent with previous fi ndings, 13 and probably represents FNP nurses' eff orts to ensure children's protection. In view of previous programme impact on maltreatment and length of hospital stay for injuries, 3 a case can be made for examining serious injuries in such trials-an outcome much more consistent with previous eff ects.
Those responsible for delivering FNP in the UK must now determine next steps. Continued assessment is essential as increased eff ort is focused on mothers who need FNP the most, and intensifi ed support is given to nurses tackling challenging behaviour, such as maternal smoking and pregnancy planning. The results of Robling and colleagues' trial 2 underscore why we cannot simply disseminate programmes without assessing them, and why, to accelerate construction of a solid early-intervention evidence base, we need to ensure that results and insights from previous studies are integrated thoroughly into the designs of new ones.
David Olds
Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA david.olds@ucdenver.edu
